Rebecca L. Dandeker; Partner, Morgan, Lewis & Bockius LLP
Rebecca L. Dandeker, JD, is a partner in the Washington D.C. office of Morgan, Lewis & Bockius, LLP. Her practice involves legal and regulatory counseling in the areas of pharmaceuticals, dietary supplements, cosmetics, and alternative therapies. She advises clients on NDA, 505(b) (2), ANDA and BLA approval pathways. Ms. Dandeker has a J.D. from Georgetown University Law Center and a B.S. from Liberty University.
This course will provide an explanation of Federal laws and regulations applicable to pharmaceutical labeling and advertising, as well as federal authority to investigate and take enforcement action against violative drug labeling and advertising. It will review FDA requirementts relevant to all drug labeling and advertising, and those that are specific to over-the-counter drugs and prescription drugs. Label content and format requirements will be explained, along with the exemptions from and modifications to the full labeling requirements. In addition to the FDA requirements, there will be a thorough review of other agency requirements, including FTC advertising standards, and PTO and CBP marking requirements, among others. FDA’s drug product listing requirements will also be explained.